- Home
- GV vs APVO Comparison
GV vs APVO Comparison
Compare GV & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- APVO
- Stock Information
- Founded
- GV 2013
- APVO 2016
- Country
- GV Canada
- APVO United States
- Employees
- GV N/A
- APVO N/A
- Industry
- GV Other Consumer Services
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- APVO Health Care
- Exchange
- GV Nasdaq
- APVO Nasdaq
- Market Cap
- GV 5.8M
- APVO 5.4M
- IPO Year
- GV 2022
- APVO N/A
- Fundamental
- Price
- GV $1.56
- APVO $3.47
- Analyst Decision
- GV
- APVO Strong Buy
- Analyst Count
- GV 0
- APVO 1
- Target Price
- GV N/A
- APVO $296.00
- AVG Volume (30 Days)
- GV 64.0K
- APVO 44.0K
- Earning Date
- GV 03-04-2025
- APVO 03-04-2025
- Dividend Yield
- GV N/A
- APVO N/A
- EPS Growth
- GV N/A
- APVO N/A
- EPS
- GV 0.32
- APVO N/A
- Revenue
- GV $9,380,985.00
- APVO N/A
- Revenue This Year
- GV N/A
- APVO N/A
- Revenue Next Year
- GV N/A
- APVO N/A
- P/E Ratio
- GV $4.93
- APVO N/A
- Revenue Growth
- GV 11.25
- APVO N/A
- 52 Week Low
- GV $1.00
- APVO $3.01
- 52 Week High
- GV $8.85
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- GV 42.36
- APVO 33.42
- Support Level
- GV $1.38
- APVO $3.20
- Resistance Level
- GV $1.80
- APVO $3.65
- Average True Range (ATR)
- GV 0.17
- APVO 0.34
- MACD
- GV 0.01
- APVO 0.01
- Stochastic Oscillator
- GV 50.98
- APVO 31.51
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.